Efficacy and Safety of SPARC1310 in Seasonal Allergic Rhinitis

PHASE2CompletedINTERVENTIONAL

Enrollment

222

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions

Seasonal Allergic Rhinitis

Interventions

DRUG

SPARC Placebo

Placebo

DRUG

SPARC1310 I

DRUG

SPARC1310 II

DRUG

SPARC1310 III

Trial Locations (1)

SPARC Site 1, Kingston

All Listed Sponsors

lead

Sun Pharma Advanced Research Company Limited

INDUSTRY

NCT01940146 - Efficacy and Safety of SPARC1310 in Seasonal Allergic Rhinitis | Biotech Hunter | Biotech Hunter